Two Partnerships Awarded Funding from BARDA’s Patch Forward Prize Competition, Secured by LTS

Andernach – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, has been selected as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies. The Patch Forward Prize, a part of the Project NextGen…

Source